Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on antineoplaston therapy for multiple myeloma; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2021-01-28